Eton Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Eton Pharmaceuticals

02/05/2025 11:52

Eton Pharmaceuticals Inc ETON.OQ ETON.O is expected to show a rise in quarterly revenue when it reports  results on May 13 for the period ending March 31 2025

The Deer Park Illinois-based  company is expected to report a 89.9% increase in revenue to $15.131 million from $7.97 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Eton Pharmaceuticals Inc is for earnings of 2 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Eton Pharmaceuticals Inc is $26.00​, above​ its last closing price of $16.97. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.01
0.00
-0.02
Missed
-500.6
Sep. 30 2024
-0.01
-0.01
0.03
Beat
400
Jun. 30 2024
-0.07
-0.07
-0.12
Missed
-71.4​
Mar. 31 2024
-0.07
-0.04
-0.03
Beat
33.3
​​Dec. 31 2023
-0.04
-0.04
-0.09
Missed
-125
Sep. 30 2023
-0.10
-0.10
-0.02
Beat
80​
Jun. 30 2023
-0.09
-0.09
0.15
Beat
266.7
Mar. 31 2023
-0.14
-0.14
-0.10
Beat
28.6

This summary was machine generated May 2 at 10:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)